Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
Stock Information for GlycoMimetics Inc.
Loading
Please wait while we load your information from QuoteMedia.